AnnaRachel Keating(Keating)FranklinMD
Pediatric Hematology & Oncology • Aurora, COPediatric Hematologic Oncology
Associate Professor
Dr. Franklin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
13123 E 16th Ave
Aurora, CO 80045Phone+1 720-777-1234Fax+1 720-777-7279
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology, 2001 - 2004
University of Texas Health Science Center at HoustonResidency, Internal Medicine/Pediatrics, 1997 - 2001
McGovern Medical School at UTHealthClass of 1997
Certifications & Licensure
CO State Medical License 2016 - 2025
TX State Medical License 1999 - 2016
NY State Medical License 2001 - 2006- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Haploidentical Natural Killer (NK) Cells With Epratuzumab for Relapsed Acute Lymphoblastic Leukemia (ALL) Start of enrollment: 2009 Jul 01
- Sperm Banking Among Adolescents Newly Diagnosed With Cancer: Development of a Profiling and Referral Tool Start of enrollment: 2010 Jul 01
- Fenretinide in Children With Recurrent/Resistant ALL, AML, and NHL Start of enrollment: 2010 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 32 citationsThe combination of the novel glycolysis inhibitor 3-BrOP and rapamycin is effective against neuroblastomaAlejandro G. Levy, Peter E. Zage, Lauren J. Akers, Maurizio Ghisoli, Zhao Chen
Investigational New Drugs. 2012-02-01 - 83 citationsAugmented Berlin-Frankfurt-Münster therapy in adolescents and young adults (AYAs) with acute lymphoblastic leukemia (ALL).Michael Rytting, Deborah A. Thomas, Susan O'Brien, Farhad Ravandi-Kashani, Elias J. Jabbour
Cancer. 2014-12-01 - 65 citationsEvaluation of Patients and Families With Concern for Predispositions to Hematologic Malignancies Within the Hereditary Hematologic Malignancy Clinic (HHMC).Courtney D. DiNardo, Sarah A. Bannon, Mark J. Routbort, Anna Franklin, Maureen E. Mork
Clinical Lymphoma, Myeloma & Leukemia. 2016-07-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
